Login / Signup

Comparison of two apheresis systems for autologous stem cell collections in pediatric oncology patients.

Ehud Even OrAlexandra Eden-WalkerMaria Di MolaElizabeth McDougallTal SchechterMuhammad AliGordana SvajgerAdam GassasChristoph LichtJoerg Krueger
Published in: Transfusion (2016)
Stem cell apheresis with the Optia device in children is safe and feasible with smaller blood volumes with shorter collection times.
Keyphrases
  • stem cells
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • cell therapy
  • young adults
  • palliative care
  • prognostic factors
  • bone marrow
  • mesenchymal stem cells